Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vugrin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer|January 1, 1983
VAB-6 combination chemotherapy in resected stage II-B testis cancerD Vugrin, W F Whitmore, H W Herr, et al.
Cancer|July 15, 1981
Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancerD Vugrin, W Whitmore, E Cvitkovic, et al.
Annals of Internal Medicine|July 1, 1981
VAB-6 combination chemotherapy in disseminated cancer of the testisD Vugrin, H W Herr, W F Whitmore, et al.
Neurosurgery|April 1, 1979
Cerebrospinal fluid markers in central nervous system metastases from testicular carcinomaN Sundaresan, D Vugrin, J Nisselbaum, et al.
Cancer Research|June 1, 1982
HLA antigens in patients with germ cell cancers of the testisM S Pollack, D Vugrin, W Hennessy, et al.
Cancer|May 1, 1981
Combined chemotherapy and surgery in treatment of advanced germ-cell tumorsD Vugrin, W F Whitmore, P C Sogani, et al.
Cancer|March 1, 1981
Adjuvant chemotherapy combination of vinblastine, actinomycin D, Bleomycin, and Chlorambucil following retroperitoneal lymph node dissection for stage II testis tumorD Vugrin, W F Whitmore, E Cvitkovic, et al.
American Journal of Clinical Oncology|August 1, 1984
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumorsG J Bosl, A Yagoda, W F Whitmore, et al.
The American Journal of Medicine|July 1, 1983
Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experienceG J Bosl, N L Geller, C Cirrincione, et al.
Cancer|June 1, 1983
Interrelationships of histopathology and other clinical variables in patients with germ cell tumors of the testisG J Bosl, N Geller, C Cirrincione, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer|January 1, 1983
VAB-6 combination chemotherapy in resected stage II-B testis cancerD Vugrin, W F Whitmore, H W Herr, et al.
Cancer|July 15, 1981
Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancerD Vugrin, W Whitmore, E Cvitkovic, et al.
Annals of Internal Medicine|July 1, 1981
VAB-6 combination chemotherapy in disseminated cancer of the testisD Vugrin, H W Herr, W F Whitmore, et al.
Neurosurgery|April 1, 1979
Cerebrospinal fluid markers in central nervous system metastases from testicular carcinomaN Sundaresan, D Vugrin, J Nisselbaum, et al.
Cancer Research|June 1, 1982
HLA antigens in patients with germ cell cancers of the testisM S Pollack, D Vugrin, W Hennessy, et al.
Cancer|May 1, 1981
Combined chemotherapy and surgery in treatment of advanced germ-cell tumorsD Vugrin, W F Whitmore, P C Sogani, et al.
Cancer|March 1, 1981
Adjuvant chemotherapy combination of vinblastine, actinomycin D, Bleomycin, and Chlorambucil following retroperitoneal lymph node dissection for stage II testis tumorD Vugrin, W F Whitmore, E Cvitkovic, et al.
American Journal of Clinical Oncology|August 1, 1984
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumorsG J Bosl, A Yagoda, W F Whitmore, et al.
The American Journal of Medicine|July 1, 1983
Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experienceG J Bosl, N L Geller, C Cirrincione, et al.
Cancer|June 1, 1983
Interrelationships of histopathology and other clinical variables in patients with germ cell tumors of the testisG J Bosl, N Geller, C Cirrincione, et al.
Pageof 5